Bruce Pollock
Affiliations: | University of Toronto (CAMH), Toronto, Ontario, Canada |
Google:
"Bruce Pollock"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ismail M, Straubinger T, Uchida H, et al. (2022) "MAP Bayesian modeling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patients". British Journal of Clinical Pharmacology |
| Kish SJ, O'Leary G, Mamelak M, et al. (2021) Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study. Human Psychopharmacology. e2791 |
| Reeves S, Bertrand J, Uchida H, et al. (2020) Towards safer risperidone prescribing in Alzheimer's disease. The British Journal of Psychiatry : the Journal of Mental Science. 1-8 |
| Koizumi T, Bies R, Suzuki T, et al. (2019) Fluctuations in hallucinatory experiences within a day in relation to dopamine D2 receptor blockade with antipsychotics in patients with schizophrenia European Neuropsychopharmacology. 29: S134-S135 |
| Caravaggio F, Fervaha G, Iwata Y, et al. (2017) Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia. International Journal of Geriatric Psychiatry |
| Sakurai H, Suzuki T, Bies RR, et al. (2016) Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial. The Journal of Clinical Psychiatry. 77: 1381-1390 |
| Ho T, Pollock BG, Mulsant BH, et al. (2016) R-and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. British Journal of Clinical Pharmacology |
| Davies SJ, Mulsant BH, Flint AJ, et al. (2016) SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study. Human Psychopharmacology |
| Akil A, Bies RR, Pollock BG, et al. (2015) A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation. Journal of Pharmacokinetics and Pharmacodynamics |
| Tsuboi T, Bies RR, Suzuki T, et al. (2015) Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study. Pharmacopsychiatry |